Putting chirality to work: the strategy of chiral switches.
about
Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzymeMechanistic and functional differentiation of tapentadol and tramadolPatented drug extension strategies on healthcare spending: a cost-evaluation analysisStereoselectivity of isoflurane in adhesion molecule leukocyte function-associated antigen-1Strategies for discovery and improvement of enzyme function: state of the art and opportunitiesThe significance of chirality in drug design and development.A novel whole-cell biocatalyst with NAD+ regeneration for production of chiral chemicals.Neuronal growth on L- and D-cysteine self-assembled monolayers reveals neuronal chiral sensitivityChiral inversion of 2-arylpropionyl-CoA esters by human α-methylacyl-CoA racemase 1A (P504S)--a potential mechanism for the anti-cancer effects of ibuprofen.A review of drug isomerism and its significance.A moment invariant for evaluating the chirality of three-dimensional objects.Unexpected stereochemical tolerance for the biological activity of tyroscherin.Enantiomeric separation of proton pump inhibitors on new generation chiral columns using LC and supercritical fluid chromatography.Enantiomeric separation of meptazinol and its three intermediate enantiomers by capillary electrophoresis: quantitative analysis of meptazinol in pharmaceutical formulations.Chiral toxicology: it's the same thing...only different.Enantiospecific photoresponse of sterically hindered diarylethenes for chiroptical switches and photomemories.Influence of age on the enantiomeric disposition of ibuprofen in healthy volunteersCationic bactericidal peptide 1018 does not specifically target the stringent response alarmone (p)ppGppStructural Asymmetry of Phosphodiesterase-9A and a Unique Pocket for Selective Binding of a Potent Enantiomeric InhibitorDrug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclatureDrug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications.Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential.Determination of enantiomeric compositions of analytes using novel fluorescent chiral molecular micelles and steady state fluorescence measurements.Nature versus nurture in two highly enantioselective esterases from Bacillus cereus and Thermoanaerobacter tengcongensis.Enantioselective synthesis of 3-arylquinazolin-4(3H)-ones via peptide-catalyzed atroposelective bromination.Enantioselective quantification of chiral drugs in human plasma with LC-MS/MS.Chiral determination of antidepressant drugs and their metabolites in biological samples.Enantiomeric fraction as an indicator of pharmaceutical biotransformation during wastewater treatment and in the environment--a review.Industrial applications of the Diels-Alder reaction.ECOTOXICOLOGICAL PROPERTIES OF KETOPROFEN AND THE S(+)-ENANTIOMER (DEXKETOPROFEN): BIOASSAYS IN FRESHWATER MODEL SPECIES AND BIOMARKERS IN FISH PLHC-1 CELL-LINE.Preparative chiral separation and absolute configuration of the synthetic pterocarpanquinone LQB-118.Circular Dichroism Studies on Plasmonic Nanostructures.Chiral metamaterials: enhancement and control of optical activity and circular dichroism.Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases.Urban legends of chemistry.Use of a robust dehydrogenase from an archael hyperthermophile in asymmetric catalysis-dynamic reductive kinetic resolution entry into (S)-profens.An enantioselective NADP(+)-dependent alcohol dehydrogenase responsible for cooxidative production of (3S)-5-hydroxy-3-methyl-pentanoic acid.Asymmetric 18F-fluorination for applications in positron emission tomography.Enzyme-Modified Particles for Selective Biocatalytic Hydrogenation by Hydrogen-Driven NADH Recycling.Identification and characterization of a mycobacterial NAD⁺-dependent alcohol dehydrogenase with superior reduction of diacetyl to (S)-acetoin.
P2860
Q27680712-66372B91-9473-49E3-9D0E-C361F24CF84EQ28268772-F5B90C33-5680-4903-81EE-CEC46669E883Q28533630-C8864FB9-9DFA-4E1F-9DEE-CC9192FBE3D6Q28538551-45CEE827-9250-40FE-956B-D2CD5DD8B33BQ28661877-035A0D86-6EE5-4556-A1F3-EC601C52BA14Q30997748-80B7508C-1173-4CA7-AC93-796038D22B36Q33529098-4DB80FF3-6275-457E-9DB0-033CC376A056Q33649368-DFC5047E-1389-4C99-BAF9-193B2B07C982Q34187468-4DF9898B-FC52-45FC-B4CC-3797F9871621Q34351651-32044C9A-79AF-4E5B-84B6-731B84C46584Q34509717-5590B6BA-59BB-49E4-86ED-BEDFC5CB7B9CQ34666741-EBA43542-24DB-4D11-8E3D-1260EF36922CQ34822438-7D9D19DA-C36D-4C9C-9646-C078717072EBQ34871850-440BCBE1-C873-4453-966F-D9FE1C9A6530Q34979115-A41AE23A-4AFE-4AE9-9439-6C316B6AD0BFQ35182917-E541CC08-8D7E-464F-A957-E3FC58B6C77BQ35825392-35867FFC-1B25-4FAC-BA21-A6A7E2987B11Q36183973-224AF390-5F97-4510-BBBE-F6EFF5EAF38DQ36186122-A3F65FA3-B8CE-4B65-A7CC-E58F9FF282FDQ36897629-9081B10B-D6CF-4A90-B06E-302C7D4C1D94Q36897767-DD705B66-70DF-4E81-8E53-3C032AA091F8Q37131951-E2DCF084-1850-4659-BC44-E4D66CF0AC90Q37142944-98546EBE-F2C3-40EA-A3BE-8702502AB330Q37274933-C3421CE8-086A-4FE2-B6B3-40EAAD7C02AAQ37466701-304EE55B-BB76-46CE-AE8A-CBFDBF5E166AQ37810188-3945779B-0E71-4325-A59D-8428F46DBEBCQ37810213-5F046C4E-F969-4EA2-AFCE-26BD03853CECQ37814345-D8E1FA62-0C22-42E0-B6F2-7FB299CAC423Q38085293-A69F0B19-7AAC-426D-949F-9213CFC0CB2DQ38630662-928DF4BE-D664-4FE4-8DE8-9C3453E6958FQ38839969-5D06BF2D-8FF2-42F0-8940-43C452D4F98BQ38856612-B6964C84-1ECF-4DE8-AF4B-623936D7F7B3Q39132874-D3683648-FC40-4283-AB12-F1F804D77327Q39171023-925A7D9E-D2DC-40BE-834C-14EFCC2F42B3Q39942894-F6237711-ACC9-409D-A718-8EC354EDA077Q40532053-FD945582-868B-4092-AB8D-C349C55A9C25Q40774419-7EBA45A5-B5B5-4C34-A3C1-1CFE36F6C5AFQ41174141-003D323D-4AAF-4601-904F-388E4666E492Q42177853-8A49EDF2-5D0B-4600-8807-C4572A726B9FQ44666477-3EBAC98A-CD50-480E-BB81-F349C7FEAD8B
P2860
Putting chirality to work: the strategy of chiral switches.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Putting chirality to work: the strategy of chiral switches.
@ast
Putting chirality to work: the strategy of chiral switches.
@en
Putting chirality to work: the strategy of chiral switches.
@nl
type
label
Putting chirality to work: the strategy of chiral switches.
@ast
Putting chirality to work: the strategy of chiral switches.
@en
Putting chirality to work: the strategy of chiral switches.
@nl
prefLabel
Putting chirality to work: the strategy of chiral switches.
@ast
Putting chirality to work: the strategy of chiral switches.
@en
Putting chirality to work: the strategy of chiral switches.
@nl
P2093
P356
P1476
Putting chirality to work: the strategy of chiral switches.
@en
P2093
Hava Caner
Israel Agranat
John Caldwell
P2888
P304
P356
10.1038/NRD915
P577
2002-10-01T00:00:00Z